Trials / Completed
CompletedNCT05021133
Tele-Navigation of Lung Cancer Screening (Tele-Navi LCS)
Tele-Navigation of Lung Cancer Screening
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 22 (actual)
- Sponsor
- University of Massachusetts, Worcester · Academic / Other
- Sex
- All
- Age
- 50 Years – 77 Years
- Healthy volunteers
- Not accepted
Summary
Adherence to annual follow up is critical to achieving mortality benefits and optimizing cost-effectiveness of lung cancer screening (LCS). However, adherence to LCS follow-up in the real world is suboptimal. Using telehealth, the investigators will co-create Tele-Navigation of Lung Cancer Screening with patients and LCS stakeholders as an intervention to promote adherence of follow-up LCS. The investigators will then implement the Tele-Navi LCS intervention to a pilot sample of patients and evaluate its feasibility in the primary care setting. The investigators will measure the number of patient participants who completed Tele-Navi LCS and follow-up LCS within 180 days from Tele-Navi LCS.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Tele-Navi LCS | Tele-Navi of LCS includes: telehealth coaching from a Tele-Navigator for patients undergoing LCS using a video or telephone call |
Timeline
- Start date
- 2023-06-05
- Primary completion
- 2023-08-11
- Completion
- 2025-12-12
- First posted
- 2021-08-25
- Last updated
- 2026-01-08
- Results posted
- 2024-08-29
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05021133. Inclusion in this directory is not an endorsement.